Betiatide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Betiatide
DrugBank Accession Number
DB14082
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Structure
Weight
Average: 367.38
Monoisotopic: 367.083806453
Chemical Formula
C15H17N3O6S
Synonyms
  • Betiatida
  • Betiatide
External IDs
  • MP 600
  • MP-600

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Diagnostic agentRenal structural abnormalities and trauma•••••••••••••••••• ••••••••••••••••••• ••••••• •••••••••••• ••• ••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Technescan MAG3Injection, powder, lyophilized, for solution1 mg/1IntravenousCurium US LLC1990-06-15Not applicableUS flag
TechneScan MAG3Injection, powder, lyophilized, for solution1 mg/1IntravenousMallinckrodt1990-06-152017-07-01US flag
TECHNETIUM Tc 99m MERTIATIDEInjection, powder, lyophilized, for solution1 mg/1IntravenousJubilant DraxImage Inc., dba Jubilant Radiopharma2023-03-31Not applicableUS flag
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Kit for the Preparation of Technetium Tc99m MertiatideInjection, powder, lyophilized, for solution1 mg/1IntravenousSun Pharmaceutical Industries, Inc.2019-09-02Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
9NV2SR34P8
CAS number
103725-47-9
InChI Key
VDPYMEBVIDZKMD-UHFFFAOYSA-N
InChI
InChI=1S/C15H17N3O6S/c19-11(16-6-12(20)18-8-14(22)23)7-17-13(21)9-25-15(24)10-4-2-1-3-5-10/h1-5H,6-9H2,(H,16,19)(H,17,21)(H,18,20)(H,22,23)
IUPAC Name
2-(2-{2-[2-(benzoylsulfanyl)acetamido]acetamido}acetamido)acetic acid
SMILES
OC(=O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)C1=CC=CC=C1

References

General References
  1. DailyMed Label: KIT FOR THE PREPARATION OF TECHNETIUM TC99M MERTIATIDE [Link]
ChemSpider
161231
RxNav
194098
ChEBI
136015
ChEMBL
CHEMBL3183117
ZINC
ZINC000006095847

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
KitIntravenous
KitIntravenous1 mg
Injection, powder, lyophilized, for solutionIntravenous1 mg
Injection, powder, for solutionIntravenous
Injection, powder, lyophilized, for solutionIntravenous1 mg/1
Injection, powder, for solutionIntravenous1 mg
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.107 mg/mLALOGPS
logP-0.36ALOGPS
logP-1.4Chemaxon
logS-3.5ALOGPS
pKa (Strongest Acidic)3.64Chemaxon
pKa (Strongest Basic)-4.5Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area141.67 Å2Chemaxon
Rotatable Bond Count10Chemaxon
Refractivity89.02 m3·mol-1Chemaxon
Polarizability35.47 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0pvi-0559000000-667b70e75b79e39bbdd8
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-002r-4911000000-95af90eb0639f4f27014
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-1900000000-2fd1b1f5918fe860984e
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00y0-9540000000-ace22cd0d127732ea601
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-3900000000-795176bd4820bdcfd1d5
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-05ds-9720000000-fcdf70090410fef59b74
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-196.6071644
predicted
DarkChem Lite v0.1.0
[M-H]-175.64638
predicted
DeepCCS 1.0 (2019)
[M+H]+196.5510644
predicted
DarkChem Lite v0.1.0
[M+H]+178.00441
predicted
DeepCCS 1.0 (2019)
[M+Na]+195.3983644
predicted
DarkChem Lite v0.1.0
[M+Na]+184.83337
predicted
DeepCCS 1.0 (2019)

Drug created at June 17, 2018 22:12 / Updated at February 21, 2021 18:54